scispace - formally typeset
S

Subhadra C. Gunawardana

Researcher at Vanderbilt University

Publications -  17
Citations -  1410

Subhadra C. Gunawardana is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Insulin & Adipose tissue. The author has an hindex of 9, co-authored 15 publications receiving 1221 citations. Previous affiliations of Subhadra C. Gunawardana include Vanderbilt University Medical Center.

Papers
More filters
Journal ArticleDOI

Ablation of PRDM16 and Beige Adipose Causes Metabolic Dysfunction and a Subcutaneous to Visceral Fat Switch

TL;DR: It is shown that adipocyte-specific deletion of the coregulatory protein PRDM16 caused minimal effects on classical brown fat but markedly inhibited beige adipocyte function in subcutaneous fat following cold exposure or β3-agonist treatment, indicating that PRDM 16 and beige fat cells are required for the "browning" of white fat and the healthful effects of sub cutaneous adipose tissue.
Journal ArticleDOI

Direct Effect of Cholesterol on Insulin Secretion: A Novel Mechanism for Pancreatic β-Cell Dysfunction

TL;DR: This study finds a direct link between elevated serum cholesterol and reduced insulin secretion from pancreatic β-cells, with normal secretion restored by cholesterol depletion, and demonstrates that excess cholesterol inhibits secretion by downregulation of metabolism through increased neuronal nitric oxide synthase dimerization.
Journal ArticleDOI

Reversal of Type 1 Diabetes in Mice by Brown Adipose Tissue Transplant

TL;DR: It is proposed that the combined action of multiple adipokines establishes a new equilibrium in the animal that allows for chronic glycemic control without insulin, and this work shows that subcutaneous transplants of embryonic brown adipose tissue (BAT) can correct T1D in streptozotocin-treated mice with severely impaired glucose tolerance and significant loss of adiposity.
Journal ArticleDOI

Insulin-independent reversal of type 1 diabetes in nonobese diabetic mice with brown adipose tissue transplant

TL;DR: The potential for insulin-independent reversal of autoimmune-induced T1D with BAT transplants is demonstrated and IGF-I is implicate as a likely mediator in the resulting equilibrium.
Journal ArticleDOI

Benefits of healthy adipose tissue in the treatment of diabetes

TL;DR: Recent studies on mouse models show that type 1 diabetes can be reversed without insulin through subcutaneous transplantation of embryonic brown adipose tissue, which leads to replenishment of recipients' white adipose tissues; increase of a number of beneficial adipokines; and fast and long-lasting euglycemia.